Asthma Drug Can Block SARS-Cov-2 Protein Finds IISC Researchers
“Promising Breakthrough: Common Asthma Drug Montelukast Emerges as Potential Weapon Against SARS-CoV-2, IISc Study Finds” In a groundbreaking revelation, researchers at the Indian Institute of Science (IISc) in Bengaluru have…
Share